Navigation Links
New approach to vaccine development provides potent, long-lasting immunity

By training a group of human subjects to operate a robot-controlled joystick, Johns Hopkins researchers have shown that the slower the brain "learns" to control certain muscle movements, the more likely it is to remember the lesson over the long haul. The results, the investigators say, could alter rehabilitation approaches for people who have lost motor abilities to brain injuries like strokes.

In a report on the work in the May 23 issue of PLoS Biology, the researchers built on their observations that some parts of the brain learn - and forget - fast, while others learn more slowly and more lastingly. Both types of learning are critical.

"We believe our work is the first to show that motor learning involves different time scales and implies that the best strategy in rehabilitating a stroke patient should focus on slow learning because slow-learned motor skills will be maintained longer," says the report's senior author, Reza Shadmehr, Ph.D., a professor of biomedical engineering in the Institute of Basic Biomedical Sciences at Johns Hopkins.

Neuroscientists long have thought that two things are required for mastering such muscle control - time and error. Time refers to the need to "sleep on it," for the brain to somehow process and "remember" how to carefully control muscles. As for error, it's thought that mistakes help the brain and muscles fine-tune fine movements. The requirement for time and error explains why repetition of simple movements day after day is used routinely in rehabilitating partially paralyzed stroke patients and those with other brain injuries.

To test the need for time in mastering muscle control, the research team designed a simple and short task. Fourteen healthy human subjects were asked to hold onto a robot-controlled joystick and keep it from moving as the robot driver pushed repeatedly - in quick pulses - to one side. The joystick then pushed repeatedly in the opposite direction and again the subjects w
'"/>

Source:University of Pittsburgh Medical Center


Page: 1 2 3

Related biology news :

1. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
2. MSI releases moleculizer - a new approach to simulation of intracellular biochemical networks
3. Stopping smallpox in its tracks: A new anti-viral approach
4. Building a protein name dictionary from full text: a machine learning term extraction approach
5. Rensselaer researchers develop approach that predicts protein separation behavior
6. Huntingtons cure in flies lays groundwork for broader treatment approaches
7. Results of worlds first gene therapy trial for arthritis show approach safe, feasible
8. Vaginal gel may provide a new approach to HIV prevention
9. Clinical trial to test stem cell approach for children with brain injury
10. Study in Science holds promise for a new approach to drug therapy
11. U-M researchers take new approach to defeating Gram-negative bugs
Post Your Comments:
(Date:3/16/2010)... D.C., March 16, 2010 Primary care physicians agree ... they do not have the right weight management resources. ... loss, but adults who need to lose weight may ... These findings and others come from new research ... and Prevent (STOP) Obesity Alliance. , In a ...
(Date:3/16/2010)... resistance to sea lice treatments such as the ... was observed. Pyrethroid use still increased from 2008 ... Older sea lice treatments are being used again ... teflubenzuron. Hydrogen peroxide, which has not been used ... mainly under controlled conditions in wellboats. , The ...
(Date:3/16/2010)... major report by an international research team explores the ... the economy and human health. , Global meat production ... double its present level by 2050, according to a ... team of scientists and policy experts. The impact of ... for human health, the environment and the global economy, ...
Breaking Biology News(10 mins):STOP Obesity Alliance surveys show doctors, patients share role in weight loss, but ask, now what? 2STOP Obesity Alliance surveys show doctors, patients share role in weight loss, but ask, now what? 3Major report reveals the environmental and social impact of the 'livestock revolution' 2Major report reveals the environmental and social impact of the 'livestock revolution' 3Major report reveals the environmental and social impact of the 'livestock revolution' 4Abbott Hosts Conference Call for Second Quarter Earnings 49896 1RIEMSER Announces Upcoming Chicago Bone Grafting Workshop 49894 1RIEMSER Announces Upcoming Chicago Bone Grafting Workshop 49894 2Stay Upbeat Active to Keep the Mind Young 49889 1Stay Upbeat Active to Keep the Mind Young 49889 2Stay Upbeat Active to Keep the Mind Young 49889 3
... Laboratory (CSHL) will play a central role in an ... the National Science Foundation (NSF). The Collaborative will define ... have global implications. , The idea is to ... transform the way plant science is done, and that ...
... has awarded a University of Arizonaled team $50 million ... within which to answer plant biology,s grand challenge questions, ... has the capacity to address. The project will unite ... the world for the first time ever to provide ...
... of complex, three-dimensional nanoscale structures and the ability ... now possible with a process developed by researchers ... the rapid evaporation of solvent from simple inks, ... nanofibers, stacked arrays of nanofibers and continuously wound ...
Other Biology News:Cold Spring Harbor Laboratory to play central role addressing key questions in plant biology 2Cold Spring Harbor Laboratory to play central role addressing key questions in plant biology 3UA-led research team awarded $50 million to solve plant biology's grand challenge questions 2UA-led research team awarded $50 million to solve plant biology's grand challenge questions 3UA-led research team awarded $50 million to solve plant biology's grand challenge questions 4UA-led research team awarded $50 million to solve plant biology's grand challenge questions 5New process makes nanofibers in complex shapes and unlimited lengths 2
(Date:3/17/2010)... Dan Maher , Senior Vice President of Product Development of BioMarin, will present a company update at the Barclays Capital Global Healthcare Conference in Miami ... ... , ... ... ...
(Date:3/17/2010)... Technologies recently launched a newly revised software program that will allow ... ... Orangeburg, NY (Vocus) March 17, 2010 -- DHS Technologies recently ... design their own unique shelter solution. , , , , ,VTAP ... allows users to simultaneously build 2-D and 3-D renderings of Deployable ...
(Date:3/16/2010)... 2010A Materials Design client and colleague ( www.materialsdesign.com ), ... R&D Center, has been honored with two GM R&D ... of Interfacial Tribology, Multi-scale Modeling of High-temperature Deformation in ... honor of John M. Campbell, a former scientific director ... his efforts to promote GM scientific research. The award ...
(Date:3/16/2010)... Foundation (GCF) and the Claudia Cohen Research Foundation announce today that Dr. Paul ... GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher.  The prize is being presented at ... San Francisco March 14-17, 2010 . , ... ... , ...
Breaking Biology Technology:BioMarin to Present at the Barclays Capital Global Healthcare Conference 2BioMarin to Present at the Barclays Capital Global Healthcare Conference 3DHS Technologies Launches VTAP 2.0 2Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 2Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 3Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 4Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 5
... April 30 Tigris Pharmaceuticals, Inc., a privately held ... on its novel molecule, AFP-464, during the recent AACR ... represents a significant advancement in the treatment of Triple ... of invasive breast cancer," stated Edmundo Muniz, M.D., Ph.D., ...
... Educational Webinar "How Organizations Can Make the Transition to ... Virtify, Inc. , , CAMBRIDGE, Mass., April ... the market leader in Enterprise Content Compliance solutions for ... ), a provider of Enterprise Compliance and Quality Management ...
... 30 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ... for the first quarter ended March 31, 2009. , ... first quarter in what has been a difficult business ... and CEO of Angiotech. "Sales in our proprietary Surgical ...
Other Biology Technology:Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 2Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 3Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 4Event Alert: 'SPL R4 Compliance and its Impact on Regulatory Submission Processes' 2Event Alert: 'SPL R4 Compliance and its Impact on Regulatory Submission Processes' 3Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 2Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 3Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 4Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 5Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 6Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 7Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 8Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 9Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 10Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 11Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 12Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 13Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 14Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 15Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 16Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 17Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 18Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 19Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 20Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 21